Electroacupuncture Improves Gastrointestinal Motility in Rats with Functional Dyspepsia via the GDNF/GFRα1/PI3K/Akt Signaling Pathway
- PMID: 40779005
- DOI: 10.1007/s11596-025-00086-4
Electroacupuncture Improves Gastrointestinal Motility in Rats with Functional Dyspepsia via the GDNF/GFRα1/PI3K/Akt Signaling Pathway
Abstract
Objective: Abnormal gastrointestinal motility plays a crucial role in the pathogenesis of functional dyspepsia (FD). Although electroacupuncture (EA) has demonstrated efficacy in FD treatment, its precise mechanism remains unclear. This study aimed to elucidate the specific mechanism through which EA improves gastrointestinal motility in FD.
Methods: Physiological indices, including body weight, food intake, gastrointestinal motility, and gastrointestinal morphology, were utilized to assess the FD model in rats. EA interventions were applied at meridian points, as well as non-meridian points and non-acupoints, in FD model rats. The effects of EA at zusanli (ST36) and taichong (LR3) on gastrointestinal motility in FD model rats were elucidated using gastrointestinal motility test indices. Techniques such as Western blotting, quantitative real-time PCR, and immunofluorescence were employed to determine the specific mechanisms by which EA improved gastrointestinal motility in FD model rats.
Results: Multifactorial stress intervention could be used to effectively establish an FD rat model. EA at ST36 and LR3 significantly improved gastrointestinal motility. Furthermore, EA at ST36 and LR3 upregulated the protein expression of glial cell line-derived neurotrophic factor (GDNF), GDNF family receptor alpha 1 (GFRα1), phosphatidylinositol 3-kinase (PI3K), and protein kinase B (Akt), along with their mRNA expression levels and the number of enteric glial cells (EGCs).
Conclusions: EA was capable of increasing the number of EGCs by activating the GDNF/GFRα1/PI3K/Akt signaling pathway, thereby improving gastrointestinal motility in FD.
Keywords: Electroacupuncture; Enteric glial cell; Enteric nervous system; Functional dyspepsia; Gastrointestinal motility.
© 2025. The Author(s), under exclusive licence to Huazhong University of Science and Technology.
Conflict of interest statement
Declarations. Conflict of Interest: The authors declare that they have no competing interests. Ethics Approval and Consent to Participate: All procedures were conducted in accordance with the relevant guidelines, and the experimental protocols were approved by the Ethics Committee of Hubei University of Traditional Chinese Medicine (Approval No.: HUCMS 202205002). Consent for Publication: Not applicable.
Similar articles
-
Electroacupuncture at ST36 improves gastrointestinal motility disorders by promoting enteric nervous system regeneration through GDNF/Ret signaling in diabetic mice.J Integr Med. 2025 Jul 23:S2095-4964(25)00109-8. doi: 10.1016/j.joim.2025.07.007. Online ahead of print. J Integr Med. 2025. PMID: 40846518
-
[Electroacupuncture of "Jiaji"(EX-B2) improves asthma by reducing airway inflammation and regulating PI3K/AKT/mTOR signaling pathway in rats with allergic asthma].Zhen Ci Yan Jiu. 2025 Jun 25;50(6):666-674. doi: 10.13702/j.1000-0607.20241336. Zhen Ci Yan Jiu. 2025. PMID: 40551649 Chinese.
-
Electroacupuncture at ST36 ameliorates gastric dysmotility in rats with diabetic gastroparesis via the nucleus tractus solitarius-vagal axis.World J Gastroenterol. 2025 Jun 7;31(21):107395. doi: 10.3748/wjg.v31.i21.107395. World J Gastroenterol. 2025. PMID: 40538511 Free PMC article.
-
Acupuncture for functional dyspepsia.Cochrane Database Syst Rev. 2014 Oct 13;2014(10):CD008487. doi: 10.1002/14651858.CD008487.pub2. Cochrane Database Syst Rev. 2014. PMID: 25306866 Free PMC article.
-
Proton pump inhibitors for functional dyspepsia.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011194. doi: 10.1002/14651858.CD011194.pub3. Cochrane Database Syst Rev. 2017. PMID: 29161458 Free PMC article.
References
-
- Ford AC, Mahadeva S, Carbone MF, et al. Functional dyspepsia. Lancet. 2020;396(10263):1689–1702. - PubMed
-
- Potter MDE, Talley NJ. Editorial: new insights into the global prevalence of uninvestigated and functional dyspepsia. Aliment Pharmacol Ther. 2020;52(8):1407–1408. - PubMed
-
- Drago L, Meroni G, Pistone D, et al. Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies. J Int Med Res. 2021;49(1):1–13.
-
- Long YQ, Xu WL, Li LX, et al. Characteristics and Risk Factors of Functional Dyspepsia Fulfilling the Rome IV Criteria Overlapping With Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China. J Neurogastroenterol Motil. 2024;30(2):184–193. - PubMed - PMC
-
- Olson CG, Travers P, Lacy BE. Current opinion: functional dyspepsia. Curr Opin Gastroenterol. 2024;40(6):470–476. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical